Monte Rosa Therapeutics Stock Forecast

Sell candidate since Jul 31, 2026

The Monte Rosa Therapeutics, Inc. stock price fell by -27.16% on the last day (Friday, 31st Jul 2026) from $22.68 to $16.52. During the last trading day the stock fluctuated 13.32% from a day low at $14.87 to a day high of $16.85. The price has fallen in 7 of the last 10 days and is down by -32.74% for this period. Volume has increased on the last day by 6 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 7 million shares were bought and sold for approximately $123.35 million.

Given the current short-term trend, the stock is expected to rise 27.49% during the next 3 months and, with a 90% probability hold a price between $21.06 and $32.46 at the end of this 3-month period.

GLUE Signals & Forecast

There are few to no technical positive signals at the moment. The Monte Rosa Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $21.60 and $21.90. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, July 17, 2026, and so far it has fallen -32.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Monte Rosa Therapeutics, Inc. stock

Monte Rosa Therapeutics, Inc. finds support from accumulated volume at $16.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.98 between high and low, or 13.32%. For the last week, the stock has had daily average volatility of 7.94%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLUE) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Monte Rosa Therapeutics, Inc. to open at $16.08, and during the day (based on 14 day Average True Range), to move between $15.58 and $17.46, which gives a possible trading interval of +/-$1.89 (+/-12.13%) up or down from last closing price. If Monte Rosa Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.37 (0.91%) than the resistance at $17.00 (2.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Monte Rosa Therapeutics, Inc. stock A Buy?

The Monte Rosa Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Monte Rosa Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.560 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $16.08 ( 2.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk